checkAd
    Startseite > Aktien > TheraVet > Nachrichten
    TheraVet Aktie
    0,6280
     
    EUR
    -2,79 %
    -0,0180 EUR
    Letzter Kurs 09:59:01 Frankfurt
    0,6280
     
    EUR
    3.190 STK
    Geldkurs 09:59:02
    0,7160
     
    EUR
    2.793 STK
    Briefkurs 09:59:02
    ISIN: BE0974387194 · WKN: A3CSTJ · SYM: 31A · Belgien

    Neueste Nachrichten

    TheraVet Unveils Its Development Strategy to Address the Equine Market
    07.05.24 · Business Wire (engl.) · TheraVet
    TheraVet reports Full-Year 2023 Financial Results and Provides the Preparatory Documents for the General Meeting of June 6th, 2024
    23.04.24 · Business Wire (engl.) · TheraVet
    TheraVet Reports 2023 Full Year and 2024 First Quarter Revenues
    10.04.24 · Business Wire (engl.) · TheraVet
    TheraVet: BIOCERA-VET is Now Available for the Management of Dental and Orthopedics Conditions in Horses
    13.03.24 · Business Wire (engl.) · TheraVet
    BIOCERA-VET Is Now Available for the Management of Dental and Orthopedics Conditions in Horses
    13.03.24 · Business Wire (engl.) · TheraVet
    TheraVet Retains a Leading US Veterinary Consulting Firm to Help Strategize Company Growth on the US Market
    20.02.24 · Business Wire (engl.) · TheraVet
    TheraVet Strengthens Its Intellectual Property With the Issuance of a Patent on VISCO-VET Technology in Europe, Israël & Singapore
    30.01.24 · Business Wire (engl.) · TheraVet
    TheraVet Reports an 99% Increase in BIOCERA-VET Units Sold in Q4 2023
    23.01.24 · Business Wire (engl.) · TheraVet
    TheraVet: Commercial Launch of BIOCERA-VET in Germany
    17.01.24 · Business Wire (engl.) · TheraVet
    TheraVet: Agreement with Alcyon Italia for the Distribution of BIOCERA-VET Product Line in Italy
    09.01.24 · Business Wire (engl.) · TheraVet
    TheraVet Reports Significant Success of Its Last Educational Webinar on Canine Osteosarcoma Co-Organized With Veterinary Instrumentation
    04.01.24 · Business Wire (engl.) · TheraVet
    TheraVet Reports Further Achievements on Its Osteosarcoma Program
    06.12.23 · Business Wire (engl.) · TheraVet